Two experimental compounds prevent one of the cellular events that is a likely contributor to fetal alcohol syndrome (FAS), according to a new study supported by the National Institute on Alcohol ...

Researchers for Scripps Research Institute and Eli Lilly have found that a compound called MTIP blocks a brain chemical, triggering a response that can stop excessive drinking, reduce the effects of a ...

One of the new compounds, CP-601932, has been shown in a clinical study to be safe in humans, notes Bartlett. She recommends a clinical study to evaluate the compound's efficacy and potential benefits ...

A pharmaceutical product used to treat bacterial infections could be a key player in helping treat alcohol use disorder. Susan E. Bergeson, Ph.D., associate professor in the department of pharmacology ...